Shah NA, Paul S, Parveen S, Bhat MH, Ali I, Kadla SA. Therapeutic outcome of saroglitazar, a peroxisome proliferator activated receptor α/γ agonist in diabetic and non-diabetic metabolic dysfunction associated steatotic liver disease. Int J Basic Clin Pharmacol [Internet]. 2025 Jun. 24 [cited 2025 Oct. 23];14(4):519-25. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5904